Small molecules targeting ubiquitination to control inflammatory diseases

Area of Science:

• Biochemistry
• Molecular Biology
• Pharmacology

Background:

• Protein ubiquitination and deubiquitination are crucial for cellular signaling in health and disease.
• Dysregulation of these processes is implicated in cancer, inflammation, and autoimmune disorders.
• Understanding the ubiquitination system has advanced significantly since the 1970s.

Purpose of the Study:

• To review the therapeutic potential of small molecules targeting ubiquitination enzymes.
• To summarize current technologies for discovering small molecules that modulate ubiquitination.
• To highlight the role of ubiquitination manipulation in novel treatment strategies.

Main Methods:

• Literature review of small molecule inhibitors and activators of ubiquitination enzymes.
• Analysis of technological advancements in screening and drug discovery for ubiquitination targets.
• Synthesis of information on the physiological and pathological relevance of ubiquitination.

Main Results:

• Small molecules targeting ubiquitination enzymes demonstrate significant therapeutic promise.
• Various technologies are available for identifying and developing these small molecules.
• The manipulation of ubiquitination pathways represents a promising avenue for drug development.

Conclusions:

• Targeting ubiquitination with small molecules is a viable therapeutic approach.
• Continued development of discovery technologies will accelerate the identification of novel ubiquitination modulators.
• This field holds potential for treating cancer, inflammatory, and autoimmune diseases.